Effectiveness and safety of 17β-estradiol / drospirenon для менопаузальной гормональной терапии у пациенток с риском развития метаболического синдрома
Objective: study of effectiveness and safety of indication of a combination 17β-estradiol/drospirenon in patients with various manifestations of the climacteric syndrome and risk of the metabolic syndrome development.Materials and methods. Results of two-year therapy of climacteric syndrome by 17β-e...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2016-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1595 |